• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Wy-45727的H2受体拮抗剂特性及胃酸分泌抑制特性

Characterization of the H2 receptor antagonist and gastric acid antisecretory properties of Wy-45,727.

作者信息

Nielsen S T

出版信息

J Pharmacol Exp Ther. 1987 Aug;242(2):607-13.

PMID:2886646
Abstract

Wy-45,727, structurally similar to ranitidine, was characterized in various models to define its gastric acid antisecretory potency and mechanism of action. In vitro it antagonized the histamine-induced 1) positive chronotropism in isolated guinea pig right atria (pA2 = 8.23, Schild coefficient +/- S.E.M. = 1.09 +/- 0.01), and 2) [14C]aminopyrine uptake in rat isolated gastric mucosal cells. It inhibited acid secretion in dogs (p.o.) prepared with innervated gastric pouches (ED50 = 0.2 mg/kg) and in the pylorus-ligated rat (ED50 = 0.43 mg/kg). ED50 values for ranitidine were 0.9 mg/kg (dog) and 9.97 mg/kg (rat). After an 18-hr pretreatment period with doses up to 300 mg/kg p.o., inhibition of acid secretion in the rat barely exceeded 50%, indicating that the duration of action of Wy-45,727 was not excessive. Wy-45,727 appears to be a selective histamine H2 receptor antagonist.

摘要

Wy-45727在结构上与雷尼替丁相似,在多种模型中对其进行了特性研究,以确定其胃酸分泌抑制效力和作用机制。在体外,它拮抗组胺诱导的:1)豚鼠离体右心房的正性变时作用(pA2 = 8.23,希尔德系数±标准误 = 1.09 ± 0.01),以及2)大鼠离体胃黏膜细胞对[14C]氨基比林的摄取。它抑制用带神经支配胃小囊制备的犬(口服)的胃酸分泌(ED50 = 0.2 mg/kg)和幽门结扎大鼠的胃酸分泌(ED50 = 0.43 mg/kg)。雷尼替丁的ED50值分别为0.9 mg/kg(犬)和9.97 mg/kg(大鼠)。口服高达300 mg/kg剂量进行18小时预处理后,大鼠胃酸分泌的抑制率仅略超过50%,这表明Wy-45727的作用持续时间并不过长。Wy-45727似乎是一种选择性组胺H2受体拮抗剂。

相似文献

1
Characterization of the H2 receptor antagonist and gastric acid antisecretory properties of Wy-45,727.Wy-45727的H2受体拮抗剂特性及胃酸分泌抑制特性
J Pharmacol Exp Ther. 1987 Aug;242(2):607-13.
2
Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.ORF 17583、其他组胺H2受体拮抗剂及奥美拉唑对大鼠和犬胃酸分泌状态的影响。
J Pharmacol Exp Ther. 1987 Aug;242(2):437-42.
3
Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.新型组胺H2受体拮抗剂ORF 17578的药理学:与西咪替丁和雷尼替丁的比较。
J Pharmacol Exp Ther. 1986 May;237(2):404-10.
4
Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity.H2受体拮抗剂的结构修饰可提供H2受体后胃泌酸抑制活性。
Drugs Exp Clin Res. 1987;13(5):297-304.
5
Inhibition of gastric acid secretion by H2-receptor antagonists.H2受体拮抗剂对胃酸分泌的抑制作用。
Arch Int Pharmacodyn Ther. 1986 Jul;282(1):151-60.
6
Pharmacology of mifentidine, a novel H2-receptor antagonist.新型H2受体拮抗剂米芬替丁的药理学
Arzneimittelforschung. 1985;35(1A):451-5.
7
Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.强效长效组胺H2受体拮抗剂ORF 17910与西咪替丁和雷尼替丁的药理学比较。
J Pharmacol Exp Ther. 1986 Aug;238(2):587-93.
8
H2-receptor antagonist and gastric acid antisecretory properties of Wy-45,662.Wy-45,662的H2受体拮抗剂及胃酸分泌抑制特性
Agents Actions. 1986 Nov;19(3-4):158-63. doi: 10.1007/BF01966200.
9
A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.新型组胺H2受体拮抗剂乙溴替丁与西咪替丁、雷尼替丁和替奥替丁某些药理特性的比较。
J Pharmacol Exp Ther. 1983 Jan;224(1):171-9.
10
Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.依罗替丁的组胺H2受体拮抗作用。对大鼠胃酸分泌、胃泌素水平及非甾体抗炎药诱导的胃毒性的影响。
Arzneimittelforschung. 1997 Apr;47(4A):439-46.

引用本文的文献

1
The role of histamine1 and histamine2 receptors in the ethanol-induced jejunal plasma protein loss.组胺1和组胺2受体在乙醇诱导的空肠血浆蛋白丢失中的作用。
Agents Actions. 1992 Mar;35(3-4):163-9. doi: 10.1007/BF01997495.